Skip to main content
Log in

Clinical outcomes of aortic repair in young adult patients with ACTA2 mutations

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

Actin, alpha-2, smooth muscle, aorta (ACTA2) mutations are one of the major causes of familial thoracic aortic aneurysms and dissections. The aim of this study was to review our clinical results of young adult patients with aortic disease caused by ACTA2 mutations.

Methods

We reviewed the medical records of 251 patients (<50 years old) who underwent surgery for thoracic aortic diseases between 2004 and 2014. Among them, nine patients (3.5%) had ACTA2 mutations. Their average age was 35 years (range 22–47) and two patients (22.2%) were males. No patients fulfilled the diagnostic criteria for Marfan syndrome. Preoperative diagnoses included annulo-aortic ectasia (n = 2), localized dissection of the sinus of Valsalva (n = 2), acute type B aortic dissection (n = 1), and chronic type B (n = 4). Eight patients (88.9%) had hypertension.

Results

A thoracoabdominal aortic replacement was required in three patients who had descending replacement for residual chronic type B aortic dissection. A patient who had thoracic endovascular aortic repair for complicated acute type B aortic dissection showed no aortic dilatation for 7 years after TEVAR. Histological results revealed cystic medial necrosis (CMN) in most cases (7/8; 87.5%).

Conclusion

Surgical outcomes for patients with ACTA2 mutations were satisfactory. CMN was a major histological finding and family history of aortic event was detected in only half of the patients with ACTA2 mutations. Despite no characteristic physical findings besides hypertension, connective tissue disease including ACTA2 mutations should be considered for aortic dissection in young adult patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9.

    Article  CAS  PubMed  Google Scholar 

  2. Regalado ES, Guo DC, Prakash S, Bensend TA, Flynn K, Estrera A, et al. Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet. 2015;8:457–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Morisaki H, Akutsu K, Ogino H, Kondo N, Yamanaka I, Tsutsumi Y, et al. Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD). Hum Mutat. 2009;30:1406–11.

    Article  CAS  PubMed  Google Scholar 

  4. Pomianowski P, Elefteriades JA. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg. 2013;2:271–9.

    PubMed  PubMed Central  Google Scholar 

  5. Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488–93.

    Article  CAS  PubMed  Google Scholar 

  6. Germain DP. Clinical and genetic features of vascular Ehlers–Danlos syndrome. Ann Vasc Surg. 2002;16:391–7.

    Article  PubMed  Google Scholar 

  7. Seike Y, Minatoya K, Sasaki H, Tanaka H. Recurrent aortic regurgitation after valve-sparing aortic root replacement due to dilatation of a previously implanted Valsalva graft. Interact Cardiovasc Thorac Surg. 2016;22:241–2.

    Article  PubMed  Google Scholar 

  8. Schlatmann TJ, Becker AE. Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol. 1977;39:13–20.

    Article  CAS  PubMed  Google Scholar 

  9. Attias D, Stheneur C, Roy C, Collod-Beroud G, Detaint D, Faivre L, et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation. 2009;120:2541–9.

    Article  CAS  PubMed  Google Scholar 

  10. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1960;1995(26):60–9.

    Google Scholar 

  11. LeMaire SA, Russell L. Epidemiology of thoracic aortic dissection. Nat Rev Cardiol. 2011;8:103–13.

    Article  PubMed  Google Scholar 

  12. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II brockade and aortic-root dilation in Marfan’s syndrome. N Eng J Med. 2008;358:2787–95.

    Article  CAS  Google Scholar 

  13. Franken R, den Hartog AW, Radonic T, Micha D, Maugeri A, van Dijk FS, et al. Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circ Cardiovasc Genet. 2015;8:383–8.

    Article  CAS  PubMed  Google Scholar 

  14. Regalado ES, Guo DC, Estrera AL, Buja LM, Milewicz DM. Acute aortic dissections with pregnancy in women with ACTA2 mutations. Am J Med Genet A. 2014;64:106–12.

    Article  Google Scholar 

  15. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of marfan syndrome. Circ Res. 2001;88:37–43.

    Article  CAS  PubMed  Google Scholar 

  16. Girdauskas E, Kuntze T, Borger MA, Doenst T, Mochalski M, Walther T, et al. Long-term prognosis of type A aortic dissection in non-Marfan patients with histologic pattern of cystic medial necrosis. Ann Thorac Surg. 2008;85:972–7.

    Article  PubMed  Google Scholar 

  17. Ueda T, Shimizu H, Aeba R, Shin H, Katogi T, Yozu R, et al. Prognosis of Marfan and non-Marfan patients with cystic medial necrosis of the aorta. Jpn J Thorac Cardiovasc Surg. 1999;47:73–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Minatoya.

Ethics declarations

Conflict of interest

All authors have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seike, Y., Minatoya, K., Sasaki, H. et al. Clinical outcomes of aortic repair in young adult patients with ACTA2 mutations. Gen Thorac Cardiovasc Surg 65, 686–691 (2017). https://doi.org/10.1007/s11748-017-0810-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-017-0810-0

Keywords

Navigation